Accuray ARAY
NASDAQ ARAY
$0.30 +0.01 (+2.55%)
At close: Aug 20, 2026 · 1:26 PM UTC

Accuray (ARAY) Net Income towards Common Stockholders (2010 - 2026)

Accuray (ARAY) posted quarterly Net Income towards Common Stockholders of -$12.2 million for Q1 2026, down 348.01% year-over-year from $4.9 million in Q1 2025, and up 14.2% quarter-over-quarter from -$14.2 million in Q4 2025.

Accuray (ARAY) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Accuray's Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at -$12.2 million for Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders fell 348.01% year-over-year to -$12.2 million; the TTM figure through Mar 2026 stood at -$54.9 million (down 3168.57% YoY), while the FY2025 annual figure was -$1.6 million, up 89.77% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$12.2 million, up from -$14.2 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $2.5 million in Q4 2024, with the low at -$120.5 million in Q2 2023.
  • The 5-year median for Net Income towards Common Stockholders is -$6.7 million (2023), against an average of -$13.9 million.
  • The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders tumbled 1191.44% in 2022, then soared 126.37% in 2024.
  • Accuray's Net Income towards Common Stockholders stood at -$1.9 million in 2022, then slumped by 413.39% to -$9.6 million in 2023, then jumped by 126.37% to $2.5 million in 2024, then plunged by 658.57% to -$14.2 million in 2025, then grew by 14.2% to -$12.2 million in 2026.
  • Business Quant data shows ARAY's Net Income towards Common Stockholders at -$12.2 million in Q1 2026, -$14.2 million in Q4 2025, and -$21.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn 928.00 Mn
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn 1.28 Bn
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn 907.00 Mn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn 621.86 Mn
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn 201.00 Mn
10 Accuray 37.50 Mn -2.20 Mn 25.29 Mn -12.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.16 Mn
Dec 31, 2025 -14.17 Mn
Sep 30, 2025 -21.68 Mn
Jun 30, 2025 -6.90 Mn
Mar 31, 2025 -2.71 Mn
Dec 31, 2024 2.54 Mn
Sep 30, 2024 -3.95 Mn
Jun 30, 2024 2.45 Mn
Mar 31, 2024 -18.93 Mn
Dec 31, 2023 -9.62 Mn
Sep 30, 2023 -2.97 Mn
Jun 30, 2023 -120.47 Mn
Mar 31, 2023 -6.72 Mn
Dec 31, 2022 -1.87 Mn
Sep 30, 2022 -5.45 Mn
Jun 30, 2022 -11.35 Mn
Mar 31, 2022 -1.96 Mn
Dec 31, 2021 179,000.00
Sep 30, 2021 -1.03 Mn
Jun 30, 2021 1.04 Mn